Corvus Pharmaceuticals Inc (CRVS) — Net Asset Quality Index

Latest as of March 2026: 95.1%

Corvus Pharmaceuticals Inc (CRVS) has a Net Asset Quality Index of 95.1% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $253.19 Million minus total liabilities of $12.52 Million yields net assets of $240.68 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Corvus Pharmaceuticals Inc defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Quality Index

95.1%
Equity / Total Assets

Net Assets

$240.68 Million
USD

Total Assets

$253.19 Million
USD

Total Liabilities

$12.52 Million
USD

Corvus Pharmaceuticals Inc Net Asset Quality Index Over Time (2014–2025)

This chart shows how Corvus Pharmaceuticals Inc's Net Asset Quality Index has evolved across 12 annual periods from 2014 to 2025. As of March 2026, the index stands at 95.1%, representing net assets of $240.68 Million against total assets of $253.19 Million USD. Explore cash efficiency ratio of Corvus Pharmaceuticals Inc to assess how effectively this company generates cash.

Annual Net Asset Quality Index for Corvus Pharmaceuticals Inc (2014–2025)

The table below presents the year-by-year Net Asset Quality Index for Corvus Pharmaceuticals Inc from 2014 to 2025, covering 12 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see CRVS market cap.

Year Quality Index Net Assets (USD) Total Assets Total Liabilities Change (pp)
2025 86.1% $61.20 Million $71.12 Million $9.91 Million ▲ +38.8 pp
2024 47.3% $32.57 Million $68.91 Million $36.34 Million ▼ -37.7 pp
2023 84.9% $38.68 Million $45.55 Million $6.87 Million ▲ +2.7 pp
2022 82.2% $56.12 Million $68.24 Million $12.12 Million ▼ -6.5 pp
2021 88.8% $97.16 Million $109.45 Million $12.29 Million ▲ +4.4 pp
2020 84.4% $72.15 Million $85.53 Million $13.38 Million ▼ -0.7 pp
2019 85.0% $71.11 Million $83.65 Million $12.54 Million ▼ -8.3 pp
2018 93.3% $110.34 Million $118.23 Million $7.90 Million ▲ +3.8 pp
2017 89.5% $84.83 Million $94.78 Million $9.94 Million ▼ -5.2 pp
2016 94.8% $132.80 Million $140.15 Million $7.35 Million ▲ +126.3 pp
2015 -31.6% $-31.10 Million $98.46 Million $129.56 Million ▼ -30.3 pp
2014 -1.3% $-159.00K $12.53 Million $12.69 Million
pp = percentage points